Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi

BACKGROUND: The World Health Organization (WHO) has targeted a reduction in viral hepatitis-related mortality by 65% and incidence by 90% by 2030, necessitating enhanced hepatitis B treatment and prevention programmes in low- and middle-income countries. Hepatitis B e antigen (HBeAg) status is used...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockdale, Alexander J., Silungwe, Niza M., Shawa, Isaac Thom, Kreuels, Benno, Gordon, Melita A., Geretti, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157469/
https://www.ncbi.nlm.nih.gov/pubmed/34044776
http://dx.doi.org/10.1186/s12879-021-06134-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157469/
https://www.ncbi.nlm.nih.gov/pubmed/34044776
http://dx.doi.org/10.1186/s12879-021-06134-3

Ejemplares similares